LIGAND PHARMACEUTICALS INCORPORATED Deferred Income Tax Liabilities, Net
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Income Tax Liabilities, Net of $21.65 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-07
- 2026-06-30: Deferred Income Tax Liabilities, Net $21.65M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $22.61M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $36.02M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $22.67M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-06-30 | $21.65M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $22.61M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $36.02M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $22.67M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $32.25M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $29.38M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $32.52M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $46.40M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $30.13M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $50.61M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $31.62M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $32.59M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $27.66M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $30.01M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $30.61M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $29.83M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $42.67M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $39.48M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $30.86M 10-K · filed 2023-02-28 | $59.09M 10-K · filed 2022-02-28 |
| 2021-09-30 | $63.03M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $60.05M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $56.81M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $64.60M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $13.51M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $23.34M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $21.77M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $32.94M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $3.76M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $694.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.61M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |